China has been engaged in the R&D and manufacturing of semi-automatic coagulation analyzers for over a decade, and based on the data from the website of the NMPA, in 2024 and 2025 (as od 15 August), a total of 2 instruments from 2 manufacturers have obtained registration certificates...

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China. Latest news

To make fusion energy a viable resource for the world’s energy grid, researchers need to understand the turbulent motion of plasmas: a mix of ions and electrons swirling around in reactor vessels.

Ortho Clinical Diagnostics announced preliminary financial results for the fourth quarter after the close of the market on Thursday, saying it expects total revenues of between $520 million and $522 million, up approximately 1 percent year over year from $517 million.

Thermo Fisher Scientific, the world leader in serving science, and PeproTech, a leading developer and manufacturer of recombinant proteins, today announced that Thermo Fisher completed its acquisition of PeproTech on December 30, 2021 for a total cash purchase price of approximately $1.85 billion.

On January 7, Hotgen Biotech released a performance forecast. The company expects the net profit attributable to the shareholders of the listed company from January to December 2021 to be CNY 2 billion to CNY 2.35 billion, with a year-on-year change of 1684.65% to 1996.97%.

Illumina said on Wednesday that it has entered into a codevelopment agreement with SomaLogic to create multiplexed, high-throughput proteomics assays with next-generation sequencing-based readout.

When a patient receives a kidney transplant, doctors carefully monitor them for signs of rejection in several ways, including biopsy. However, this procedure is invasive and can only detect issues at a late stage.

On January 4th, the four-channel iPonatic nucleic acid detection analyzer of Sansure Biotech was certified by FDA. This is another global authority certification obtained after the approval of China NMPA and the European Union CE certification.

Researchers in China have identified dozens of causal relationships between blood metabolites and the microbes in the human gut.

Calibre Scientific said on Tuesday that it has acquired French life science reagent and instrument distributor AmpliTech.

Cure Genetics, a Chinese biotech startup that focuses on the treatment of cancers and genetic diseases, has secured $60 million in a Series B round of financing led by China-focused private equity (PE) firm Advantech Capital